RETINALGENIX TECHNOLOGIES INC. Proceeds from Warrant Exercises
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Proceeds from Warrant Exercises of $25.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2025-03-31
- RETINALGENIX TECHNOLOGIES INC. proceeds from warrant exercises for the quarter ending 2023-06-30 was $0.00.
- RETINALGENIX TECHNOLOGIES INC. proceeds from warrant exercises for the quarter ending 2023-03-31 was $25.00K.
- RETINALGENIX TECHNOLOGIES INC. proceeds from warrant exercises for the quarter ending 2022-12-31 was $0.00.
- RETINALGENIX TECHNOLOGIES INC. proceeds from warrant exercises for the quarter ending 2022-09-30 was $25.00K.
- RETINALGENIX TECHNOLOGIES INC. proceeds from warrant exercises for fiscal 2022 was $25.00K, a 85.19% increase from fiscal 2021.
- RETINALGENIX TECHNOLOGIES INC. proceeds from warrant exercises for fiscal 2021 was $13.50K.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-08-14 | $25.00K 10-Q · filed 2023-08-14 | $25.00K derived: sum of 3 quarters · filed 2025-03-31 | $50.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | $25.00K 10-Q/A · filed 2023-05-30 | $25.00K derived: sum of 2 quarters · filed 2025-03-31 | $50.00K derived: sum of 3 quarters · filed 2025-03-31 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $25.00K derived: sum of 2 quarters · filed 2025-03-31 | $25.00K 10-K · filed 2025-03-31 | |
| 2022-09-30 | $25.00K 10-Q · filed 2022-11-17 | $25.00K 10-Q · filed 2023-11-14 | ||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-15 | $0.00 derived: sum of 2 quarters · filed 2023-06-15 | $13.50K 10-K/A · filed 2023-06-15 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-17 | $13.50K 10-Q · filed 2022-11-17 | ||
| 2021-06-30 | $13.50K 10-Q · filed 2022-08-19 |